Global Precision Medicine Market Insights, Forecast to 2025

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Precision Medicine Market, By Application

7.1.  Precision Medicine Market, by Application, 2021-2028

7.1.1.    Diagnostics

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Therapeutics

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Medical Devices

7.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Precision Medicine Market, End Use

8.1.  Precision Medicine Market, End Use, 2021-2028

8.1.1.    Home care

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Hospitals

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Clinical Laboratories

8.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Precision Medicine Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Application (2016-2028)

9.1.2.    Market Revenue and Forecast, End Use (2016-2028)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Application (2016-2028)

9.1.3.2.        Market Revenue and Forecast, End Use (2016-2028)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Application (2016-2028)

9.1.4.2.        Market Revenue and Forecast, End Use (2016-2028)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Application (2016-2028)

9.2.2.    Market Revenue and Forecast, End Use (2016-2028)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Application (2016-2028)

9.2.3.2.        Market Revenue and Forecast, End Use (2016-2028)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Application (2016-2028)

9.2.4.2.        Market Revenue and Forecast, End Use (2016-2028)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Application (2016-2028)

9.2.5.2.        Market Revenue and Forecast, End Use (2016-2028)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Application (2016-2028)

9.2.6.2.        Market Revenue and Forecast, End Use (2016-2028)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Application (2016-2028)

9.3.2.    Market Revenue and Forecast, End Use (2016-2028)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Application (2016-2028)

9.3.3.2.        Market Revenue and Forecast, End Use (2016-2028)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Application (2016-2028)

9.3.4.2.        Market Revenue and Forecast, End Use (2016-2028)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Application (2016-2028)

9.3.5.2.        Market Revenue and Forecast, End Use (2016-2028)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Application (2016-2028)

9.3.6.2.        Market Revenue and Forecast, End Use (2016-2028)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Application (2016-2028)

9.4.2.    Market Revenue and Forecast, End Use (2016-2028)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Application (2016-2028)

9.4.3.2.        Market Revenue and Forecast, End Use (2016-2028)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Application (2016-2028)

9.4.4.2.        Market Revenue and Forecast, End Use (2016-2028)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Application (2016-2028)

9.4.5.2.        Market Revenue and Forecast, End Use (2016-2028)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Application (2016-2028)

9.4.6.2.        Market Revenue and Forecast, End Use (2016-2028)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Application (2016-2028)

9.5.2.    Market Revenue and Forecast, End Use (2016-2028)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Application (2016-2028)

9.5.3.2.        Market Revenue and Forecast, End Use (2016-2028)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Application (2016-2028)

9.5.4.2.        Market Revenue and Forecast, End Use (2016-2028)

Chapter 10.  Company Profiles

10.1.              Abbott Laboratories

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Biogen Inc.

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Foundation Medicine Inc.

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Illumina, Inc.

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Precision Biologics

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              IBM Watson

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Siemens Healthineers

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Janssen Pharmaceuticals

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              GE Healthcare.

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms